Loading news...
CANbridge Pharmaceuticals raised $98M Series D venture round, led by Lefei Sun.
This funding round does not have an about section yet.
| Investor | Firm Type |
|---|
| Partner |
|---|
WuXi AppTecLEAD | Venture Capital | — |
General AtlanticLEAD | Venture Capital | — |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Public | — |
This company has completed 5 funding rounds. Current round is highlighted.
Total Raised
$214M
Top Valuation
-
CANbridge Pharmaceuticals raised $98M in a Series D round.
The round was announced on 02/18/20.
The round was led by Lefei Sun, WuXi AppTec.